Randomized placebo-controlled trial of oral tannin supplementation on COVID-19 symptoms, gut dysbiosis and cytokine response

The clinical study aim was to investigate whether a tannin-based dietary supplementation could improve the efficacy of standard-of-care treatment of hospitalized COVID-19 patients by restoring gut microbiota function. Adverse events and immunomodulation post-tannin supplementation were also investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Molino, Silvia, Pisarevsky, Andrea, Badu, Shyam, Wu, Qinglong, Mingorance, Fabiana López, Vega, Patricia, Stefanolo, Juan Pablo, Repetti, Julieta, Ludueña, Guillermina, Pepa, Pablo, Olmos, Juan Ignacio, Fermepin, Marcelo Rodriguez, Uehara, Tatiana, Viciani, Elisa, Castagnetti, Andrea, Savidge, Tor, Piskorz, María Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708634/
https://www.ncbi.nlm.nih.gov/pubmed/36467850
http://dx.doi.org/10.1016/j.jff.2022.105356

Ejemplares similares

Ejemplares similares